Geron Corporation
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy

Abstract:

The invention provides methods for determining the susceptibility of cancer patients to developing adverse reactions if treated with a telomerase inhibitor drug by measurement of telomere length in appropriate cells of the patient prior to initiation of the telomerase inhibitor treatment.